Brooks (BRKS) Acquires Celigo Cell Cytometer Line from Cyntellect
Tweet
Share
E-mailGet Alerts BRKS Hot Sheet
Join SI Premium – FREE
Brooks Automation, Inc. (Nasdaq: BRKS), has completed the acquisition of the Celigo Cell Cytometer product line from Cyntellect Inc., a privately held life sciences Company based in San Diego.
As part of the transaction, the majority of Cyntellect's employees who have supported Celigo since inception are being moved to Brooks' nearby facility in Poway, CA, providing for a seamless transition of the key engineering, manufacturing, and R&D capabilities, as well as the field based sales and support personnel.
As part of the transaction, the majority of Cyntellect's employees who have supported Celigo since inception are being moved to Brooks' nearby facility in Poway, CA, providing for a seamless transition of the key engineering, manufacturing, and R&D capabilities, as well as the field based sales and support personnel.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Real and RE/MAX Holdings receive court approval for merger
- Nuvectis Pharma (NVCT) files $200M mixed shelf
- FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
Create E-mail Alert Related Categories
Corporate News, FDA, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
